OTRK News and Press, Ontrak Inc. From 08/10/22

Ontrak (NASDAQ: OTRK) , a leading artificial intelligence and telehealth-enabled healthcare company, has closed its previously announced registered direct offering for $4 million. The offering was with institutional investors and involved the purchase and sale of shares of the companyȁ...

Image source: The Motley Fool. Ontrak, Inc. (NASDAQ: OTRK) Q2 2022 Earnings Call Aug 09, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Ontrak, Inc. (OTRK) Q2 2022 Earnings Call Transcript

Ontrak, Inc. (OTRK) Q2 2022 Earnings Conference Call August 09, 2022 04:30 PM ET Company Participants Caroline Paul - IR Terren Peizer - CEO James Park - CFO Mary Osborne - CCO Brandon LaVerne - COO Conference Call Participants Presentation ...

The following slide deck was published by Ontrak, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Ontrak, Inc. 2022 Q2 - Results - Earnings Call Presentation

Ontrak press release ( NASDAQ: OTRK ): Q2 Non-GAAP EPS of -$0.63 misses by $0.10 . Revenue of $3.9M (-85.3% Y/Y) misses by $0.75M . Company pays off in full its $19.2 million outstanding loan balance; draws down $5.0 million on Keep Well Agreement Company r...

Q2 Revenue of $3.9 million Company pays off in full its $19.2 million outstanding loan balance; draws down $5.0 million on Keep Well Agreement Company raises $3.5 million, net, in a registered direct offering of shares of Company's common stock with institutional inv...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com We’re starting off Tuesday with a breakdown of the biggest pre-market stock movers traders need to know about! Moving stocks this morning are earnings reports, heavy trading ...

Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”) announced today that it has closed its previously announced registered direct offering with institutional investors for the purchase and sale of shares of its common stock at a purchase price of $0.8...

Gainers: Quoin Pharmaceuticals ( QNRX ) +45% . Context Therapeutics CNTX +13% . Rhythm Pharmaceuticals RYTM +13% . Harmony Biosciences HRMY +10% . Nautilus Biotechnology NAUT +9% . Losers: Ontrak OTRK -43% . Phathom Pharmaceutical...

Eliem Therapeutics ELYM -25% on report to discontinue development of lead asset as mid-stage pain trial fails . Mobile Global Esports (MGAM) -14% . Senti Biosciences ( SNTI ) -10% . Celyad Oncology ( CYAD ) -11% . Eos Energy Enterprises EOSE...